期刊文献+

β-葡萄糖醛酸苷酶的研究进展 被引量:1

Research Progress in β-Glucuronidase
下载PDF
导出
摘要 目的:综述β-葡萄糖醛酸苷酶结构、性质及其生物学功能研究进展。方法:查阅近年来国内外β-葡萄糖醛酸苷酶的相关文献报道,并进行归纳,分析,总结。结果:β-葡萄糖醛酸苷酶晶体结构由三个不同的结构域组成,其基因突变中最常见的为错义突变,会造成相应酶活性改变,从而引发黏多糖贮积症Ⅶ型等系列病变,对其在抗体导向酶解前体药疗法、酶替代疗法等领域的研究也在不断深入。结论:β-葡萄糖醛酸苷酶作为人体重要酸性水解酶,可发生多种基因突变,其在医药领域及疾病诊断等方面发挥了重要的作用,已越来越成为研究的热点。 Objective:To summarize the structure, properties and biological functions ofβ-glucuronidase. Methods:By referring to the relevant literatures at home and abroad onβ-glucuronidase in recent years, this paper induced, analyzed and drew conclusions. Results:The crystal structure of humanβ-glucuronidase is comprised of three distinct structural domains. The most common mutation of β-glucuronidase is missense mutation, which results in the change of enzyme activity, and then induces a series of pathological chan-ges like MPSⅦ. The researches on β-glucuronidase used in antibody-directed enzyme prodrug drug therapy and enzyme replacement therapy are becoming deeper and deeper. Conclusion:β-Glucuronidase as an important acid hydrolytic enzyme in human has a variety of genetic mutations, and plays an important role in the fields of medicine and disease diagnosis, which has become one of research hotspots.
出处 《中国药师》 CAS 2017年第10期1834-1838,共5页 China Pharmacist
基金 国家自然科学基金面上项目(编号:81273591) 国家自然科学基金青年项目(编号:81503161) 中央高校基本科研业务费专项资金(编号:2014YGYL003 2016YXZD050)
关键词 Β-葡萄糖醛酸苷酶 晶体结构 基因突变 功能 β-Glucuronidase Crystal structure Mutation Function
  • 相关文献

参考文献8

二级参考文献61

  • 1邹麓,朱佳琪,徐艳媛.β-葡萄糖醛酸酶对于肝癌,胰腺癌的临床意义[J].中国民族民间医药,2009,18(3):12-13. 被引量:1
  • 2韩文秀,孟翔凌,徐阿曼,黄赵刚,夏泉.内源性β-葡萄糖醛酸酶与原发性肝内胆管结石关系的研究[J].消化外科,2006,5(5):361-363. 被引量:5
  • 3Zampino MG,Labianca R,Beretta G,et.al.Rectal cancer[J].Crit Rev Oncol Hematol,2004,51(2):121-143.
  • 4Mahshall JC.The gut as a potenital trigger of exercise-induced inflammatory responses[J].Can J Physiol Pharmacal,1998,76:479-484.
  • 5许国铭,李兆申.胆道疾病:内镜诊断与治疗学[M].上海:第二军医大学出版社,2006:257.
  • 6Skar V, Skar AG, Stromme JH. Beta-glucuronidase activity related to bacterial growth in CGmmon bile duct bile in gallstone patients. Stand J Gastmenterol, 1988,23 (1) :83 -90.
  • 7Osnes T, Sandstad O, Skar V, Osnes M. Beta-Glucuronidase in CGmmon duct bile, methodological aspects, variation of pH optima and relation to gallstones. Scand J Clin Lab Invest, 1997,57 (4) :307 - 315.
  • 8Swindsinski A , khikin M , Pahlig H , et al. Time dependent changes in the CGncentration and type of bacterial sequences found in choles- terol gallstone. Hepatology, 1998,27 ( 3 ) :662 - 665.
  • 9Nakai K, Tazuma S, Nishioka T, Chayama K. Inhibition of cholester- ol crystallization under bilirubin deCGnjugation: partial characteriza- tion of mechanisms whereby infected bile accelerates pigment stoneformation. Biochim Biophys Acta,2003, 10 (13) :48 -54.
  • 10Oyabu H,et al, Non bacterial transformation of bilirubin in bile. Dig Dis Sci, 1984,329 (7) : 809.

共引文献46

同被引文献23

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部